To determine if the increased LOH frequency was only associated with tumor suppressor gene or genes under a selective pressure for LOH, we surveyed the entire genome for LOH frequencies in ESCO2 wild-type and deficient tumors (S1 and S2 Tables). The gene discussed is ESCO2; the disease is neoplasm.